Clorox Company (The) (CLX) Getting Somewhat Positive Media Coverage, Study Shows

News coverage about Clorox Company (The) (NYSE:CLX) has been trending somewhat positive recently, Accern reports. Accern scores the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Clorox Company (The) earned a news impact score of 0.17 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 46.9678306353735 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

• Clorox Co (CLX) Files 10-K for the Fiscal Year Ended on June 30, 2017 (finance.yahoo.com)
• Clorox’s (CLX) Long-Term Strategy Bode Well: Here’s Why (zacks.com)
• Clorox's (CLX) Long-Term Strategy Bode Well: Here's Why (finance.yahoo.com)
• Tale of the Ticker: Clorox Co (CLX), First Trust Dow Jones Internet Index Fund (FDN) Moving on Volume – Sparta Review (spartareview.com)
• Clorox Company (The) (CLX) Position Cut by KAMES CAPITAL plc – ExpressNewsline (expressnewsline.com)

A number of research analysts recently commented on CLX shares. Jefferies Group LLC started coverage on Clorox Company (The) in a report on Tuesday, April 18th. They issued a “hold” rating and a $138.00 price target on the stock. Vetr cut Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price target on the stock. in a report on Tuesday, April 18th. Royal Bank Of Canada set a $115.00 price objective on Clorox Company (The) and gave the stock a “hold” rating in a research note on Monday, April 24th. BMO Capital Markets reaffirmed a “buy” rating and issued a $136.00 price objective on shares of Clorox Company (The) in a research note on Thursday, May 4th. Finally, UBS AG reaffirmed a “sell” rating and issued a $121.00 price objective (up previously from $117.00) on shares of Clorox Company (The) in a research note on Friday, May 5th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. Clorox Company (The) presently has a consensus rating of “Hold” and a consensus target price of $129.05.

Clorox Company (CLX) traded up 0.54% during trading on Tuesday, hitting $136.30. The stock had a trading volume of 399,659 shares. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The company’s 50 day moving average is $133.40 and its 200-day moving average is $133.95. The company has a market cap of $17.60 billion, a PE ratio of 25.55 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last released its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.30 earnings per share. On average, equities research analysts predict that Clorox Company will post $5.67 earnings per share for the current year.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.